• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES INTRACLUDE INTRA-AORTIC OCCLUSION DEVICE; CLAMP, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES INTRACLUDE INTRA-AORTIC OCCLUSION DEVICE; CLAMP, VASCULAR Back to Search Results
Model Number ICF100
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Aortic Dissection (2491)
Event Date 09/13/2016
Event Type  Injury  
Manufacturer Narrative
Product evaluation was not performed as the device was discarded by the hospital staff.The clinical observation was unable to be confirmed.Manufacturing records were unable to be reviewed as no lot number was provided.A manufacturing deficiency or product deficiency was not identified.Based on the information received, operational context and patient's anatomical condition contributed to this event.The instructions for use (ifu) were reviewed and no inadequacies were identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.Injuries to the aorta or artery through which it is inserted are listed as a potential complication in the product ifu.The ifu provides the following warnings: "ensure the guidewire precedes the occlusion device to prevent damage to aortic valve or artery.Failure to advance over a guidewire may result in dissection or perforation of the artery.If a dissection or perforation is detected, do not initiate or continue bypass as it may propagate dissection.Do not advance the occlusion device if resistance is felt.Inability to easily advance the occlusion device may indicate vascular disease or injury." the training material instructs physicians to perform pre-operative tests such as a ct angiography prior to the case to detect vascular complications which are undetected by cardiac catheterization.In case where the presence of certain anatomical conditions exist, femoral arterial perfusion may be contraindicated.The fmea adequately addresses potential causes of failure and the associated hazards.The complaint trend was assessed and was found to be in control.No corrective or preventative actions are required at this time.Trends will continue to be monitored through the use of edwards quality systems and if action is required, appropriate investigation will be performed.
 
Event Description
Edwards was notified of an aortic dissection that occurred after difficulty placing an intra-aortic occlusion device.The surgeon cannulated the right femoral artery with a cannula with no problem.He then attempted to insert the occlusion device, which would not pass through the patient's ascending aorta.He opted to use an another cannula in the left femoral artery and left the original cannula in the right femoral artery.Echo had been used during guidewire placement, but fluoro was brought in only after encountering difficulty placing the occlusion device.The imaging showed the patient had a very tortuous femoral artery.There were no other anatomical variances.After closing the left atrium following the robotic mvr, the patient developed an aortic dissection.As a result of the dissection, the patient required aortic valve replacement along with replacement of the aortic root and ascending aorta with concomitant right coronary artery bypass grafting.A ct angiogram was not performed prior to the procedure as the patient was transferred form an outside facility.The surgeon believed that there was damage to the intima of the femoral artery when trying to insert the occlusion device.This likely resulted in a tear in the femoral, which extended to the aorta.The patient left the or in stable condition.Subsequently, patient suffered from a parietal lobe stroke.On postoperative day one (1), did not have doppler pulse in the left leg.A ct angiogram showed the patient had dissections of all of his major blood vessels.He became acidotic and expired in the afternoon of post-operative day one due to the dissection caused ischemia to multiple organ systems.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTRACLUDE INTRA-AORTIC OCCLUSION DEVICE
Type of Device
CLAMP, VASCULAR
Manufacturer (Section D)
EDWARDS LIFESCIENCES
12050 lone peak parkway
draper UT
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer Contact
neil landry
1 edwards way
irvine, CA 92614
9492502289
MDR Report Key6015333
MDR Text Key56912012
Report Number3008500478-2016-00037
Device Sequence Number1
Product Code DXC
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K113182
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Health Professional
Type of Report Initial
Report Date 09/13/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberICF100
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/13/2016
Initial Date FDA Received10/10/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age73 YR
Patient Weight80
-
-